Orgenesis Inc.
Orgenesis Inc. (ORGS) Revenue
Annual & quarterly revenue history · segment & region breakdown
ORGS · revenue · updated Jun 9, 2026
Core revenue metrics
Trailing 12 monthsOrgenesis Inc. trailing twelve-month (TTM) revenue is $-0.01B, a decrease of 98.53% year-over-year from $0.00B in FY2023.
Revenue trend
2023 – 2008 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2023-12-31 | $0.00B | -$0.04B | -98.53% |
| 2022-12-31 | $0.04B | +$0.00B | +1.47% |
| 2021-12-31 | $0.04B | +$0.03B | +363.96% |
| 2020-12-31 | $0.01B | -$0.03B | -76.99% |
| 2019-12-31 | $0.03B | +$0.01B | +78.27% |
| 2018-11-30 | $0.02B | +$0.01B | +84.90% |
| 2017-12-31 | $0.01B | +$0.00B | +57.71% |
| 2016-11-30 | $0.01B | +$0.00B | +115.10% |
| 2015-11-30 | $0.00B | +$0.00B | — |
| 2014-11-30 | $0.00B | +$0.00B | — |
Revenue breakdown
Segment & GeographyAbout Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Orgenesis Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Orgenesis Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from Orgenesis Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
ORGS revenue · 4 questionsORGS's trailing twelve-month (TTM) revenue is $-0.01B. That is a decrease of 98.53% year-over-year from $0.00B in FY2023.
▸ Source: FMP · Orgenesis Inc. SEC filings · GAAP · Orgenesis Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026